Skip to main content
MADRIGAL PHARMACEUTICALS, INC. logo

MADRIGAL PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · MDGL ISIN · US5588681057 LEI · 549300CHIMT2EUSNJB60 US Manufacturing
Open in API
Filings indexed 1,022 across all filing types
Latest filing 2021-02-25 Earnings Release
Country US United States of America
Listing US MDGL

About MADRIGAL PHARMACEUTICALS, INC.

https://www.madrigalpharma.com/

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious and progressive liver disease with high unmet medical need. The company's research led to the first U.S. Food and Drug Administration (FDA)-approved treatment for MASH. Madrigal's therapeutic goal is to halt or reverse liver scarring (fibrosis) and resolve the disease before patients experience severe complications, including cirrhosis, liver failure, and the need for transplantation.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 25, 2021, reporting the results of operations and financial condition for the fourth fiscal quarter and fiscal year ended December 31, 2020. It states that a press release announcing these results is furnished as Exhibit 99.1 and incorporated by reference. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length is 3660 characters, which is relatively short and consistent with a current report filing that announces earnings results rather than the full earnings release or annual report. According to the filing definitions, initial announcements of quarterly or periodical financial results (key highlights only) correspond to an Earnings Release (ER). Since this is a Form 8-K announcing earnings results via a press release, the appropriate classification is Earnings Release (ER).
2021-02-25 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-23 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-23 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-23 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-23 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.